Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (The Framingham Heart Study)

被引:925
作者
Singh, JP
Evans, JC
Levy, D
Larson, MG
Freed, LA
Fuller, DL
Lehman, B
Benjamin, EJ
机构
[1] NHLBI, Framingham Heart Study, Framingham, MA USA
[2] NHLBI, Bethesda, MD 20892 USA
[3] Boston Univ, Sch Med, Div Cardiol, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Div Prevent Med, Boston, MA 02118 USA
[5] Beth Israel Hosp, Div Cardiol, Boston, MA 02215 USA
[6] Beth Israel Hosp, Div Clin Epidemiol, Boston, MA 02215 USA
[7] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1016/S0002-9149(98)01064-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Little information is available on the prevalence and determinants of valvular regurgitation in the general population. This study sought to assess the prevalence and clinical determinants of mitral (MR), tricuspid (TR), and aortic (AR) regurgitation in a population-based cohort. Color Doppler echocardiography was performed in 1,696 men and 1,893 women (aged 54 +/- 10 years) attending a routine examination at the Framingham Study. After excluding technically poor echocardiograms, MR, TR, and AR were qualitatively graded from trace to severe. Multiple logistic regression analysis was used to examine the association of clinical variables with MR and TR (more than or equal to mild severity) and AR (more than or equal to trace severity). MR and TR of more than or equal to mild severity was seen In 19.0% and 14.8% of men and 19.1% and 18.4% of women, respectively, and AR of more than or equal to trace severity in 13.0% of men and 8.5% of women. The clinical determinants of MR were age (odds ratio [OR] 1.3/9.9 years, 95% confidence interval [CI] 1.2 to 1.5), hypertension (OR 1.6; 95% CI 1.2 to 2.0), and body mass index (OR 0.8/4.3 kg/m(2); 95% CI 0.7 to 0.9). The determinants of TR were age (OR 1.5/9.9 years; 95% CI 1.3 to 1.7), body mass index (OR 0.7/4.3 kg/m(2): 95% CI 0.6 to 0.8), and female gender (OR 1.2; 95% CI 1.0 to 1.6). The determinants of AR were age (OR 2.3/9.9 years; 95% CI 2.0 to 2.7) and male gender (OR 1.6; 95% CI 1.2 to 2.1). A substantial proportion of healthy men and women had detectable valvular regurgitation by color Doppler echocardiography. These data provide population-based estimates for comparison with patients taking anorectic drugs. (C) 1999 by Excerpta Medico, Inc.
引用
收藏
页码:897 / 902
页数:6
相关论文
共 27 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]   AGE-RELATED VALVULAR REGURGITATION - A STUDY BY PULSED DOPPLER ECHOCARDIOGRAPHY [J].
AKASAKA, T ;
YOSHIKAWA, J ;
YOSHIDA, K ;
OKUMACHI, F ;
KOIZUMI, K ;
SHIRATORI, K ;
TAKAO, S ;
SHAKUDO, M ;
KATO, H .
CIRCULATION, 1987, 76 (02) :262-265
[3]  
[Anonymous], 1951, AM J PUBLIC HEALTH
[4]   Prevalence of echocardiographic findings in 554 men and in 1,243 women aged >60 years in a long-term health care facility [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (03) :379-&
[5]   PULSED AND CONTINUOUS WAVE DOPPLER ECHOCARDIOGRAPHIC ASSESSMENT OF VALVULAR REGURGITATION IN NORMAL SUBJECTS [J].
BERGER, M ;
HECHT, SR ;
VANTOSH, A ;
LINGAM, U .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (07) :1540-1545
[6]  
Biava G, 1997, CORONARY ARTERY DIS, V8, P559
[7]   THE PREVALENCE OF VALVULAR REGURGITATION IN CHILDREN WITH STRUCTURALLY NORMAL HEARTS - A COLOR DOPPLER ECHOCARDIOGRAPHIC STUDY [J].
BRAND, A ;
DOLLBERG, S ;
KEREN, A .
AMERICAN HEART JOURNAL, 1992, 123 (01) :177-180
[8]  
BRAUNWALD E, 1992, HEART DISEASE TXB CA, P1007
[9]   PREVALENCE OF VALVULAR REGURGITATION BY DOPPLER ECHOCARDIOGRAPHY IN PATIENTS WITH STRUCTURALLY NORMAL HEARTS BY TWO-DIMENSIONAL ECHOCARDIOGRAPHY [J].
CHOONG, CY ;
ABASCAL, VM ;
WEYMAN, J ;
LEVINE, RA ;
GENTILE, F ;
THOMAS, JD ;
WEYMAN, AE .
AMERICAN HEART JOURNAL, 1989, 117 (03) :636-642
[10]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588